Advanced Search
LI Hao, CUI Yong. Effect of Leukemia Inhibitory Factor on Proliferation and Invasion of Non-small Cell Lung Cancer Cells and Related Mechanism[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 553-555. DOI: 10.3971/j.issn.1000-8578.2015.06.004
Citation: LI Hao, CUI Yong. Effect of Leukemia Inhibitory Factor on Proliferation and Invasion of Non-small Cell Lung Cancer Cells and Related Mechanism[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 553-555. DOI: 10.3971/j.issn.1000-8578.2015.06.004

Effect of Leukemia Inhibitory Factor on Proliferation and Invasion of Non-small Cell Lung Cancer Cells and Related Mechanism

More Information
  • Received Date: May 27, 2014
  • Revised Date: September 16, 2014
  • Objective To explore the influence of leukemia inhibitory factor(LIF) on the proliferation and invasion of non-small cell lung cancer(NSCLC) cells. Methods The expression of LIF in human NSCLC tissues and adjacent tissues were detected by fluorescent quantitative PCR and Western blot. After NSCLC cell lines A549 and Z793 were treated with recombinant LIF, we detected cell proliferation by MTT assay, cell invasion by Transwell assay, and ATK/mTOR pathway by Western blot. Results LIF expression was higher in lung cancer tissues than that in the matched adjacent tissues(P=0.0078). After A549 and Z793 cell lines were treated with recombinant LIF, the tumor cells showed a significantly higher proliferation rate and invasiveness in vitro than those in control group(P<0.01); moreover, the phosphorylated AKT level was significantly elevated and the expression of mammalian target of rapamycin(mTOR), the AKT downstream targets, was obviously up-regulated. Conclusion LIF expression is significantly increased in NSCLC cells. In addition, the ectopic expression of LIF promotes cell proliferation and invasion via activating AKT/mTOR pathway.
  • [1]
    Gao W, Xu J, Shu YQ. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer[J]. Expert Rev Respir Med, 2011, 5(5): 699-709.
    [2]
    Sun CJ, Zhang XZ, Chen Y. Therapeutic effect of erlotinib in elderly patients with advanced non-small cell lung cancer[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2012, 32(12): 1839-41.[孙长江, 张西志, 陈勇. 厄洛替尼治疗老年晚期非小细胞肺癌的疗效[J]. 南方医科大学学报, 2012, 32(12): 1839-41.]
    [3]
    Antonicelli A, Cafarotti S, Indini A, et al. EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation[J]. Int J Med Sci, 2013, 10(3): 320-30.
    [4]
    Matsushita K, Itoh S, Ikeda S, et al. LIF/STAT3/SOCS3 signaling pathway in murine bone marrow stromal cells suppresses osteoblast differentiation[J]. J Cell Biochem, 2014, 115(7): 1262-8.
    [5]
    Kuphal S, Wallner S, Bosserhoff AK. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma[J]. Exp Mol Pathol, 2013, 95(2): 156-65.
    [6]
    Kamohara H, Sakamoto K, Ishiko T, et al. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF) [J]. Res Commun Mol Pathol Pharmacol, 1994, 85(2): 13 1-40.
    [7]
    Ge Y, Cheng R, Zhou Y, et al. Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemiacells by inhibiting the activity of eukaryotic initiation factor 4E[J]. Mol Cell Biochem, 2012, 368(1-2): 17-25.
    [8]
    Suman P, Malhotra SS, Gupta SK. LIF-STAT signaling and trophoblastbiology[J]. JAKSTAT, 2013, 2(4): e25155.
    [9]
    Tarasuk M, Poungpair O, Ungsupravate D, et al. Human singlechain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity[J]. Int J Mol Med, 2014, 33 (3): 515-22.
    [10]
    Kim EY, Kim A, Kim SK, et al. Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells[J]. Respir Res, 2014, 15: 26.
    [11]
    Li X, Yang Q, Yu H, et al. LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway[J]. Oncotarget, 2014, 5(3): 788-801.
  • Related Articles

    [1]KONG Yan, DONG Qian, LI Shuguang, XU Jinrui, ZHAO Xiaohan, DENG Wenzhao, SHEN Wenbin. Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2025, 52(3): 225-232. DOI: 10.3971/j.issn.1000-8578.2025.24.0721
    [2]XIA Lili, ZHU Xinyi, ZHANG Xiwei, LI Zhengjiang, LIU Shaoyan, LU Haizhen, AN Changming. Predictive Value of Depth of Invasion of Tongue Squamous Cell Carcinoma for Cervical Lymph Node Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 675-681. DOI: 10.3971/j.issn.1000-8578.2022.21.1460
    [3]LI Haiyan, ZHOU Xuan, CHEN Yunqing, JI Huihui, SHI Weiping, WANG Chengqin, XIANG Fenggang. Expression of KIF3A in Different Gastric Mucosal Lesions, Metastatic Lymph Nodes and Its Relationship with Metastasis and Prognosis of Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 985-990. DOI: 10.3971/j.issn.1000-8578.2018.18.0627
    [4]ZHAO Ruihua, JIANG Wenjing, ZHANG Weijie, CAO Xinguang. Metastasis?associated Lung Adenocarcinoma Transcript1(MALAT1) Expression in Middle Thoracic Esophageal Squamous Cell Cancer Tissues and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1227-1230. DOI: 10.3971/j.issn.1000-8578.2015.12.012
    [5]LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
    [6]Zhen Chanjun, Zhou Zhiguo, Song Yuzhi, Qiao Xueying. Analysis of Therapeutic Effect and Prognosis of Radiotherapy for Patients with Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 90-94. DOI: 10.3971/j.issn.1000-8578.2013.01.023
    [7]LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Effects of KISS-1 Transfection on Tumor Growth of Nude Mice[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 136-140. DOI: 10.3971/j.issn.1000-8578.2010.02.004
    [8]LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Construction of Eukaryotic Expression Plasmid pcDNA3.1-KISS-1 and Its Metastasis Inhibiting Effect to EC1 Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(04): 265-269. DOI: 10.3971/j.issn.1000-8578.2009.04.002
    [9]GAO Zhao-hua. Analysis of Clinicopathologic Characteristics and Prognosis of Colorectal Cancer without Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 272-274. DOI: 10.3971/j.issn.1000-8578.2697
    [10]Huang jinqiu, . The significance of tumor angiogenesis in the invasion metastasis and judging the prognosis of gastric carcinoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 441-444.

Catalog

    Article views (1286) PDF downloads (492) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return